Cochrane Abstracts
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors versus Conventional Anticoagulants for the Treatment of Pulmonary Embolism." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434234/1/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism.
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/1/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism. Accessed December 12, 2024.
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/1/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors versus Conventional Anticoagulants for the Treatment of Pulmonary Embolism [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/1/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
ID - 434234
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/1/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
